News

Prescription Drug Monitoring Programs Still Cumbersome


 

Dr. Perrone and Dr. Nelson also wrote in their paper that PDMPs are "no panacea" to the misuse of prescription opioids. "A multimodal approach is required. Cultural change related to the expectations of patients and providers, new medications and formulations, and extensive education at many levels can contribute to a reduction in opioid misuse, even as appropriate access to this pharmacotherapy is maintained."

For information about PDMPs in your state, visit the National Alliance for Model State Drug Laws or the Alliance of States with Prescription Monitoring Programs.

Dr. Perrone and Dr. Nelson reported having no financial conflicts.

Pages

Recommended Reading

Health Reform on the Campaign Trail: The Policy & Practice Podcast
MDedge Rheumatology
Docs See Slight Raise; Revenues Fall for Groups
MDedge Rheumatology
Arkansas Project to Share Savings With Doctors
MDedge Rheumatology
Stage 2 Meaningful Use Rule Delays Implementation
MDedge Rheumatology
Care Coordination Pilot Begins: The Policy & Practice Podcast
MDedge Rheumatology
It's Official: ICD-10 Delayed a Year
MDedge Rheumatology
Employers to Cut Health Care Spending by Steering Doctor Selection
MDedge Rheumatology
Survey Finds Support for Health Reform
MDedge Rheumatology
IOM: Technology, Incentives Can Fix Broken System
MDedge Rheumatology
Rheumatologists' Earnings Up 8% in 2011
MDedge Rheumatology